Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence of Antibodies After GSK Biologicals' Meningococcal Vaccine GSK134612 in Toddlers

NCT00955682 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00955682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence of Antibodies After GSK Biologicals' Meningococcal Vaccine GSK134612 in Toddlers
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
August 25, 2009
Completion date
September 10, 2012
Enrollment
342 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

infections, meningococcal